AI in Remote Patient Monitoring (RPM) Market: Growth, Size, Share, and Trends

Report Code HIT 9321
Published in Mar, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

AI in Remote Patient Monitoring (RPM) Market by Component (Device: Wearable, Implantable, Portable; Software, Service), Indication (Cardiac, Neuro, Onco, Diabetes, Sleep, Mental Health), End User (Hospitals, Clinics, Payer), Region - Global Forecast to 2030

Overview

The global AI in remote patient monitoring market, valued at US$1551.8 billion in 2023, is forecasted to grow at a robust CAGR of 27.5%, reaching US$1,967.7 billion in 2024 and an impressive US$8,438.5 billion by 2030. The growth of the AI in remote Patient Monitoring (RPM) market is driven by the expansion of telehealth services and the rising need for easier access to healthcare. Supportive policies, like the 2025 updates from the US Centers for Medicare & Medicaid Services and the Telehealth Modernization Act, are helping expand telehealth access and improve virtual patient care. The global market is also being bolstered by AI integration, with governments like India’s National Digital Health Mission and the UK's National Health Service enhancing digital health ecosystems. On January 21, 2025, the Council of the European Union adopted a new regulation establishing the European Health Data Space (EHDS). The purpose of this legislation is to provide seamless exchange and access to health data across EU member states to facilitate cross-border healthcare services, research, and policy-making. Increasing interest in strategic partnerships is hugely boosting the scaling of RPM so that the advent of mobile technology, along with AI analytics, will continue to improve patient care. In addition, the continued growing role of AI in RPM in acute and behavioral health makes sure market growth remains continuing.

AI in Remote Patient Monitoring (RPM) Market – Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the AI in Remote Patient Monitoring (RPM) Market

Asia Pacific

The high growth rate of the Asia Pacific market can be attributed to the increasing geriatric population and rising incidence of chronic diseases; improvements in healthcare infrastructure; rapid economic growth; technological advancements in wearable remote patient monitoring devices; and increasing uptake of advanced solutions.

The key factors driving overall market growth include the growing need to expand healthcare access; advantage of integrating AI into RPM; the increasing investments in uptake of technologically advanced solutions; and the benefits offered by home care settings.

The role and impact of AI in remote patient monitoring integrated with its efficiency in combating the rising incidence of infectious diseases is expected to provide growth opportunities for market players. combating infectious diseases & epidemics are factors expected to offer significant growth opportunities for players operating in this market

The North American AI in remote patient monitoring market is expected to be worth USD 4,253.0 billion by 2030, growing at CAGR of 26.2% during the forecast period.

Data accessibility issues and regulatory barriers are expected to pose a challenge to market growth.

Global AI in Remote Patient Monitoring (RPM) Market Dynamics

DRIVER: Transforming patient care through digital innovation

Remote patient monitoring is using digital technologies to remotely monitor and transfer patient data to healthcare providers, thus transforming healthcare delivery, disease management, and patient outcomes dramatically. This is especially useful for people with chronic illnesses and fewer contact routes to care. Widespread adoption of Al in RPM is supported by Medicare, state Medicaid programs, and private health insurers. As of March 2023, 34 state Medicaid programs covered RPM, though some impose restrictions. The rise of Al-powered diagnostic tools, including 103 devices for conditions such as sleep apnea, atrial fibrillation, and epilepsy, is expected to accelerate Al in RPM's growth, with 75 FDA-approved Al/ML-enabled tools now available in the US. The accelerated rise of mHealth apps further accelerates the Remote Patient Monitoring (RPM) market, uniting wearables, sensors, and telehealth to capture real-time health information. Favorable Al reimbursement policies have solidified RPM adoption. In October 2023, the Biden administration signed an executive order that instructed Department of Health and Human Services (HHS) to develop policies for assessing and monitoring AI-based healthcare devices, with the FDA controlling medical devices under this order. Medicaid programs are to implement reimbursement policies for RPM, although requirements for coverage will continue to be state-specific. In the 2024 Physician Fee Schedule, CMS finalized its proposal to include remote monitoring services under Healthcare Common Procedure Coding System code G0511, allowing safety-net providers to bill this code multiple times per month.

RESTRAINT: Regulatory variation across regions

There are notable differences in policies and legislation that regulate AI in remote patient monitoring practice across various states and nations, and this results in a lack of specifications. For example, as wearables become increasingly popular, it is important to note that they could be regulated as medical devices based on the laws of various areas, including Europe, North America, and China. The European Medical Device Regulation 2017/745 (MDR) sets the criteria for the classification of smart wearables in the EU. It is worth noting that the definitions of medical devices differ between the EU's MDR and the US Food Drug and Cosmetic Act's Medical Device Amendments (US FD&C Act). In addition, the classification of software is particularly complex under the EU-MDR. These regulatory nuances differ across countries, especially when it comes to devices used for remote patient monitoring. The guidelines for obtaining patient consent before telemedicine visits also vary among different US states.

 

OPPORTUNITY: Growing opportunities in emerging nations

Australia, China, Japan, Singapore, India, Australia, New Zealand, Thailand, and South Korea are major AI in remote patient monitoring markets in Asia Pacific. Government initiatives for the implementation of AI in remote patient monitoring solutions, developing healthcare infrastructure, the rise in government spending on healthcare systems, growth in medical tourism, and increase in the number of skilled IT experts are major factors favoring the adoption of AI in RPM solutions in the emerging markets across the Asia Pacific region. For example, in October 2022, the Australian government spent USD 7.5 million to pilot wearable health devices and on-the-spot blood testing in remote Northern Territory communities. The money is intended to enhance health monitoring, such as monitoring blood pressure, physical symptoms, and early condition detection like sepsis. In this regard, the International Finance Corporation (IFC), a part of the World Bank Group that invests in the private sector in emerging markets, launched TechEmerge, a program designed to accelerate technology deployment in emerging markets. The first phase of this pilot program helped connect health sector innovators from India and abroad to leading healthcare providers in India for boosting the adoption of AI in remote patient monitoring.

CHALLENGES: Issues related to accuracy due to scarcity of high-quality healthcare data

AI was meant originally to support and monitor outpatient patients, but bias introduced by poor-quality data introduces the potential for hidden dangers leading to mistakes and issues with reliability. High costs, privacy concerns, fragmented data, and a shortage of qualified technologists capable of implementing and regulating AI constitute the key challenges. To highlight safety, openness, and regulation, the WHO will release a report in November 2023 titled "Recommendations on AI in Healthcare". The plan comprises data standardization, public-private partnerships, AI-backed data governance tools, and synthetic data.

Limited access to high-quality healthcare data is one of the limiting factors for accelerated AI development in remote patient monitoring (RPM). The growing diversity of organizations often results in unstructured and withheld data, causing worries over data privacy and hindering appropriate AI model training.

Global AI in Remote Patient Monitoring (RPM) Market Ecosystem Analysis

The ecosystem of AI in remote patient monitoring comprises telecommunications companies, i.e., network, connectivity, software, and hardware providers; CT tools and electronics manufacturers, i.e., the infrastructure service providers; and service & medical device providers. Healthcare providers (hospitals, health systems, physicians, ACSs, and clinics), Payers, patients/customers, health retailers, senior living/post-acute/hospice centers, start-ups, and governments and regulatory bodies are also stakeholders of this market.

AI in Remote Patient Monitoring (RPM) Market
 

By healthcare provider, the hospitals segment accounted for the largest market share in 2023

By end user, the healthcare provider, AI in remote patient monitoring market has been segmented into hospitals; ambulatory surgeries, ambulatory care centers, and other outpatient settings; long-term care & assisted living facilities; home healthcare; and other healthcare providers. As of 2023, the hospitals segment generated the largest share of the remote patient monitoring market. Among the major reasons responsible for this segment's expansion are the rising cases of chronic conditions that require sustained medical attention and management-these include diabetes, cardiovascular diseases, and obesity. Additional factors such as the application of reforms such as the Affordable Care Act, thus expanding patients' access by purchasing health insurance. Hospitals generate large volumes of data from monitoring devices, thus emphasizing the demand for adequate data management, storage, and analysis, thus propelling the growth of the remote patient monitoring market. For instance, in March 2023, Medanta (India) partnered with GE HealthCare (US) to introduce the Medanta e-ICU Command Centre, a 24/7 virtual ICU service providing advanced consultation and real-time monitoring of critically ill patients.

By healthcare providers, the home healthcare is expected to register the highest growth rate during the forecast period

By end user, the healthcare providers, AI in remote patient monitoring market has been segmented into hospitals; ambulatory surgeries, ambulatory care centers, and other outpatient settings; long-term care & assisted living facilities; home healthcare; and other healthcare providers. The home healthcare is expected to register the highest growth rate during the forecast period. The AI-empowered RPM solutions in home settings can effectively enable the management of diabetes, hypertension, and heart disease, all of which require continuous monitoring. With enhancements in wearable technology and AI analytic tools, devices are now available that collect health data in real time and offer predictive insights against health. For instance, in December 2024, CERA CARE, a healthcare startup in the UK, raised USD 150 million, attaining a valuation of more than USD 1 billion. CERA CARE is an AI technology-enabled organization that provides home care in an attempt to reduce hospitalization and promote patient outcomes.

By region, the Asia Pacific is expected to register the highest growth rate during the forecast period

By region, the AI in remote patient monitoring market is segmented into North America, the Asia Pacific, Europe, the Middle East & Africa, and Latin America. The Asia Pacific region is expected to register the highest growth rate during the forecast period. The key factors contributing to the high CAGR can be attributed to the high adoption of digital health technologies; increasing healthcare expenditure; a large target patient population; and continuous improvements in healthcare infrastructure in this region. The researchers at the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) recently designed a wearable device capable of detecting stress based on natural body reactions to pain. The flexible silver-wired device tracks changes in electrical responses over time, helping doctors monitor stress and discomfort in real-time and create personalized treatment plans remotely. Additionally, NATCO Cancer Centre (India) adopted Dozee’s AI-driven contactless Remote Patient Monitoring (RPM) system to track patients' vital signs in real time. This helps doctors catch health issues early, improve patient care, and reduce infection risks, all as part of a larger effort to upgrade hospital care in India.

Such innovations are expected to transform healthcare delivery and fuel the adopt of AI in RPM services during the forecast period.

US IS THE LARGEST MARKET SIZE IN 2023
INDIA IS THE FASTEST-GROWING MARKET IN REGION
AI in Remote Patient Monitoring (RPM) Market Region

Recent Developments of AI in Remote Patient Monitoring (RPM) Market

  • In August 2024, Medtronic (Ireland) announced the FDA approval of its Simplera Continuous Glucose Monitoring (CGM) system, offer users accurate and real-time glucose monitoring for better diabetes control.
  • In October 2024, Koninklijke Philips (Netherlands) introduced its Connected Baby Monitor (model SCD643/26) in India, offering parents advanced technology for peace of mind. Key features include HD video streaming, two-way communication, motion detection, and a range of soothing features like a night light and lullabies.
  • In February 2024, GE Healthcare (US) collaborated with Biofourmis (Boston) to integrates Biofourmis’ AI-powered, FDA-cleared algorithms with GE HealthCare’s FlexAcuity monitoring and virtual care solutions like Mural ICU and Command Center. This combination delivers proactive, personalized care through clinical-grade wearables, in-home services, and dynamic care pathways.
  • In September 2024, Roche Diabetes Care, Inc. (Switzerland) to launch continuous glucose monitoring in Europe. Roche will roll out Accu-Chek Smartguide in the Netherlands, Switzerland and Germany.

Key Market Players

Want to explore hidden markets that can drive new revenue in AI in Remote Patient Monitoring (RPM) Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2030
Base Year Considered 2023
Forecast period 2024-2030
Forecast units Million/Billion (USD)
Segments covered Component, Indication, and End-user
Geographies covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

 

Key Questions Addressed by the Report

Which are the top industry players in the global AI in remote patient monitoring market?
The top market players in the global AI in remote patient monitoring include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), Boston Scientific Corporation (US), GE HealthCare (US), ResMed (US), Roche Diabetes Care Inc. (Switzerland), OMRON Healthcare, Inc. (US), and among others.
What are the component segments included in the AI in remote patient monitoring report?
This report contains the following components:
  • Devices
    • Wearable devices
    • Implantable devices
    • Handheld & portable devices
    • Stationary devices
  • Software
  • Services
Which region dominates the global AI in remote patient monitoring market in 2023?
North America dominated the market with the largest share. The key factors driving the growth of North America in the AI in RPM market can be attributed to the rising geriatric population and subsequent increase in chronic diseases; the rising adoption of technologically advanced algorithm for RPM solutions; and the presence of leading medical device manufacturers in the region.
What are the end users profiled in the AI in remote patient monitoring market?
The report contains the following end user segments.
  • Healthcare Providers
    • Hospitals
    • Ambulatory surgery centers, ambulatory care centers, and other outpatient settings
    • Long-term care & assisted living facilities 
    • Home healthcare
    • Other healthcare providers (diagnostics & imaging centers)
  • Healthcare payers
  • Patients
  • Pharmaceutical & biotechnology companies
  • MedTech companies
  • Other end users (employer groups, government organizations, academic institutes, research centers, and others)
What is the total CAGR expected to be recorded for the AI in remote patient monitoring market during 2024−2030?
The market is expected to record a CAGR of 27.5% during 2024−2030.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the AI in Remote Patient Monitoring (RPM) Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table Of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
29
RESEARCH METHODOLOGY
34
EXECUTIVE SUMMARY
51
PREMIUM INSIGHTS
55
MARKET OVERVIEW
58
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Expanding telehealth and remote patient monitoring markets
    - Increasing prevalence of chronic diseases
    - Focus on development and adoption of mHealth applications
    - Increased government support and favorable reimbursement policies
    - Growing awareness about lifestyle management and home healthcare
    RESTRAINTS
    - Regulatory variations across regions
    - Shortage of skilled professionals to operate AI-based remote patient monitoring tools
    - Data security concerns
    OPPORTUNITIES
    - Growing demand for personalized medicines and care plans
    - Increase in partnerships and collaborations among healthcare providers and AI-based companies
    - Growth opportunities in emerging economies
    - Rising investment in AI-based remote patient monitoring solutions
    CHALLENGES
    - Scarcity of high-quality healthcare data and privacy concerns
    - Reluctance among healthcare professionals to adopt AI in remote patient monitoring devices
    - Lack of interoperability
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.4 INDUSTRY TRENDS
    SHIFT TO VALUE-BASED AND PATIENT-CENTRIC CARE
    INNOVATIONS IN WEARABLE MEDICAL TECHNOLOGIES
  • 5.5 ECOSYSTEM ANALYSIS
    ROLE IN ECOSYSTEM
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Wearable devices and sensors
    - AI and ML
    - Predictive analytics
    COMPLEMENTARY TECHNOLOGIES
    - mHealth applications
    - Cloud computing
    - Digital health platforms
    ADJACENT TECHNOLOGIES
    - Point-of-care diagnostics
    - Smart home health devices
  • 5.8 TARIFF & REGULATORY ANALYSIS
    TARIFF ANALYSIS
    - Tariff data for HS code 9018
    - Tariff data for HS code 9021
    - Tariff data for HS code 9022
    REGULATORY FRAMEWORK
    - North America
    - Europe
    - Asia Pacific
    - Middle East & Africa
    - Latin America
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.9 TRADE ANALYSIS
    TRADE ANALYSIS FOR HSN CODE 90189099
    - Import data for HSN code 90189099
    - Export data for HSN code 90189099
    TRADE ANALYSIS FOR HSN CODE 9021
    - Import data for HSN code 9021
    - Export data for HSN code 9021
    TRADE ANALYSIS FOR HSN CODE 9022
    - Import data for HSN code 9022
    - Export data for HSN code 9022
  • 5.10 PRICING ANALYSIS
    INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER, 2023
    INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY REGION, 2023
  • 5.11 PORTER’S FIVE FORCES ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF BUYERS
    THREAT OF SUBSTITUTES
    THREAT OF NEW ENTRANTS
    BARGAINING POWER OF SUPPLIERS
  • 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.13 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS
    JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS
    TOP PATENT OWNERS/APPLICANTS IN AI IN REMOTE PATIENT MONITORING MARKET
    LIST OF KEY PATENTS/PATENT APPLICATIONS
  • 5.14 UNMET NEEDS & END-USER EXPECTATIONS
    UNMET NEEDS
    END-USER EXPECTATIONS
  • 5.15 KEY CONFERENCES & EVENTS, 2025–2026
  • 5.16 CASE STUDY ANALYSIS
    ADOPTION OF MEDTRONIC LINQ II WITH ACCURHYTHM AI FOR REMOTE PATIENT MONITORING
    ADOPTION OF ZETO EEG SOLUTIONS FOR NEUROLOGY AND EPILEPSY DIAGNOSIS
    ADOPTION OF DOZEE AI-POWERED BALLISTOCARDIOGRAPHY TECHNOLOGY
  • 5.17 INVESTMENT & FUNDING SCENARIO
  • 5.18 BUSINESS MODEL ANALYSIS
    SUBSCRIPTION-BASED MODELS
    PLATFORM-AS-A-SERVICE MODELS
    SERVICE-BASED MODELS
    FREEMIUM MODELS
    COLLABORATIVE ECOSYSTEM AND PARTNERSHIP MODELS
  • 5.19 REIMBURSEMENT SCENARIO ANALYSIS
AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT
111
  • 6.1 INTRODUCTION
  • 6.2 DEVICES
    WEARABLE DEVICES
    - Rising adoption of consumer health technologies and growing trend toward preventive healthcare to drive segment
    IMPLANTABLE DEVICES
    - Development of wireless communication technologies and advancements in medical devices to spur market adoption
    HANDHELD & PORTABLE DEVICES
    - Rising consumer preference for home healthcare and self-monitoring to aid market growth
    STATIONARY DEVICES
    - Reduced hospitalizations and improved patient outcomes through timely alerts to aid market growth
  • 6.3 SOFTWARE
    EFFECTIVE TRANSFORMATION OF RAW DATA TO PERSONALIZED INSIGHTS FOR PATIENTS TO AUGMENT MARKET GROWTH
  • 6.4 SERVICES
    INCREASING NEED FOR VALUE-BASED SPECIALIZED SERVICES TO BOOST MARKET GROWTH
AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION
121
  • 7.1 INTRODUCTION
  • 7.2 ONCOLOGY
    NEED FOR IMPROVED SYMPTOM MONITORING AND PERSONALIZED TREATMENT PLANS TO DRIVE MARKET
  • 7.3 CARDIOLOGY
    INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO FUEL MARKET GROWTH
  • 7.4 NEUROLOGY
    GROWING ADOPTION OF TELEMEDICINE AND RISING NEED FOR CONTINUOUS MONITORING TO AID MARKET GROWTH
  • 7.5 DIABETES
    HIGH ADOPTION OF AI-POWERED DEVICES FOR EFFECTIVE DIABETES MANAGEMENT TO PROPEL MARKET GROWTH
  • 7.6 SLEEP DISORDERS
    AI-POWERED REMOTE PATIENT MONITORING DEVICES TO ENSURE EFFECTIVE SLEEP APNEA MANAGEMENT
  • 7.7 RESPIRATORY DISEASES
    GROWING BURDEN OF COPD AND ASTHMA IN LOW- AND MIDDLE-INCOME COUNTRIES TO SUPPORT MARKET GROWTH
  • 7.8 WELLNESS IMPROVEMENT
    RISING PREVALENCE OF OBESITY AND LIFESTYLE DISEASES TO AUGMENT MARKET GROWTH
  • 7.9 MENTAL HEALTH DISORDERS
    AI-BASED REMOTE PATIENT MONITORING TO IMPROVE ACCESS TO MENTAL HEALTH SUPPORT AND REDUCE STIGMA OF IN-PERSON THERAPY
  • 7.10 OTHER INDICATIONS
AI IN REMOTE PATIENT MONITORING MARKET, BY END USER
131
  • 8.1 INTRODUCTION
  • 8.2 HEALTHCARE PROVIDERS
    HOSPITALS
    - Rising demand for high-quality care and increasing incidence of chronic diseases to drive market
    AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS
    - AI-driven remote patient monitoring devices to enhance postoperative care, patient safety, and recovery outcomes
    LONG-TERM CARE & ASSISTED LIVING FACILITIES
    - Need for prolonged treatment for chronic diseases and high cost of hospital stays to fuel uptake
    HOME HEALTHCARE FACILITIES
    - Increased preference for at-home treatment options to drive market
    OTHER HEALTHCARE PROVIDERS
  • 8.3 HEALTHCARE PAYERS
    FAVORABLE REIMBURSEMENT SCENARIO FOR REMOTE PATIENT MONITORING SERVICES TO AUGMENT MARKET GROWTH
  • 8.4 PATIENTS
    ADVANCEMENTS IN WEARABLE DEVICES AND PERSONALIZED PATIENT CARE TO FUEL MARKET GROWTH
  • 8.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    AI-BASED REMOTE PATIENT MONITORING SOLUTIONS TO ASSIST PHARMA COMPANIES EXPAND MARKET PRESENCE
  • 8.6 MEDTECH COMPANIES
    RISING DEMAND FOR ADVANCED TECHNOLOGIES FOR REMOTE DISEASE DIAGNOSIS AND TREATMENT TO FAVOR MARKET GROWTH
  • 8.7 OTHER END USERS
AI IN REMOTE PATIENT MONITORING MARKET, BY REGION
142
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - US to dominate North American market during study period
    CANADA
    - Need to curtail healthcare costs and high penetration of smartphones and tablets to drive market
  • 9.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - High healthcare expenditure and increased preference for home monitoring to propel market growth
    UK
    - Favorable government initiatives and high demand for advanced healthcare solutions to aid market growth
    FRANCE
    - Increased adoption of connected medical devices to fuel market growth
    ITALY
    - Increased government health expenditure and high geriatric population to boost market growth
    SPAIN
    - Need to reduce healthcare costs and improve treatment quality to drive adoption of AI-based remote patient monitoring devices
    REST OF EUROPE
  • 9.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - Strong internet access and high smartphone adoption to augment market growth
    JAPAN
    - Rising geriatric population and increasing government health expenditure to aid market growth
    INDIA
    - Need to bridge gap between rural patients and urban doctors to propel market growth
    REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Favorable government initiatives and increased health expenditure to favor market growth
    MEXICO
    - Technological advancements and favorable legal policies for digital health technologies to drive market
    REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Favorable government and non-government initiatives and increased investment in healthcare infrastructure to drive market
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
213
  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS FOR AI IN REMOTE PATIENT MONITORING MARKET
  • 10.3 REVENUE ANALYSIS, 2019–2023
  • 10.4 MARKET SHARE ANALYSIS, 2023
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Component footprint
    - Indication footprint
    - End-user footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key emerging players/startups
  • 10.7 COMPANY VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 10.8 BRAND/SOFTWARE COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
COMPANY PROFILES
235
  • 11.1 KEY PLAYERS
    MEDTRONIC
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    KONINKLIJKE PHILIPS N.V.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    GE HEALTHCARE
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    BOSTON SCIENTIFIC CORPORATION
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    OMRON HEALTHCARE, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    RESMED, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    NIHON KOHDEN CORPORATION
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS)
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    IRHYTHM INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    BEIJING CHOICE ELECTRONIC TECH CO., LTD.
    - Business overview
    - Products/Services/Solutions offered
    BIOTRONIK
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    ALIVECOR, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    MASIMO
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - Recent developments
    DEXCOM, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    BIOBEAT
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    TYTOCARE LTD.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    ZETO INC.
    - Business overview
    - Products/Services/Solutions offered
    GLOOKO, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    WELLDOC, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE)
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
  • 11.2 OTHER PLAYERS
    BIOINTELLISENSE, INC.
    BLUE SPARK TECHNOLOGIES, INC.
    ACCURKARDIA, INC.
    AION BIOSYSTEMS, INC.
    BROOK INC.
APPENDIX
316
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 AI IN REMOTE PATIENT MONITORING MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 3 AI IN REMOTE PATIENT MONITORING MARKET: FACTOR ANALYSIS
  • TABLE 4 AI IN REMOTE PATIENT MONITORING MARKET: MARKET SIZING ASSUMPTIONS
  • TABLE 5 AI IN REMOTE PATIENT MONITORING MARKET: RISK ASSESSMENT
  • TABLE 6 AI IN REMOTE PATIENT MONITORING MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • TABLE 7 RECENT DEVELOPMENTS IN AI-BASED SOLUTIONS FOR REMOTE PATIENT MONITORING, JANUARY 2022–DECEMBER 2024
  • TABLE 8 AI IN REMOTE PATIENT MONITORING MARKET: ROLE IN ECOSYSTEM
  • TABLE 9 AI IN REMOTE PATIENT MONITORING MARKET: TARIFF DATA FOR HS CODE 9018
  • TABLE 10 AI IN REMOTE PATIENT MONITORING MARKET: TARIFF DATA FOR HS CODE 9021
  • TABLE 11 AI IN REMOTE PATIENT MONITORING MARKET: TARIFF DATA FOR HS CODE 9022
  • TABLE 12 REGULATORY SCENARIO OF NORTH AMERICA
  • TABLE 13 REGULATORY SCENARIO OF EUROPE
  • TABLE 14 REGULATORY SCENARIO OF ASIA PACIFIC
  • TABLE 15 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
  • TABLE 16 REGULATORY SCENARIO OF LATIN AMERICA
  • TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 TOP 10 IMPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 23 TOP 10 EXPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 24 TOP 10 IMPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 25 TOP 10 EXPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 26 TOP 10 IMPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 27 TOP 10 EXPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 28 INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER, 2023
  • TABLE 29 INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY REGION, 2023
  • TABLE 30 AI IN REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES
  • TABLE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
  • TABLE 32 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 33 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS
  • TABLE 34 AI IN REMOTE PATIENT MONITORING MARKET: LIST OF PATENTS/PATENT APPLICATIONS
  • TABLE 35 AI IN REMOTE PATIENT MONITORING MARKET: UNMET NEEDS
  • TABLE 36 AI IN REMOTE PATIENT MONITORING MARKET: END-USER EXPECTATIONS
  • TABLE 37 AI IN REMOTE PATIENT MONITORING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
  • TABLE 38 CASE STUDY 1: ADOPTION OF MEDTRONIC LINQ II WITH ACCURHYTHM AI FOR REMOTE PATIENT MONITORING
  • TABLE 39 CASE STUDY 2: ADOPTION OF ZETO EEG SOLUTIONS FOR NEUROLOGY AND EPILEPSY DIAGNOSIS
  • TABLE 40 CASE STUDY 2: ADOPTION OF DOZEE AI-POWERED BALLISTOCARDIOGRAPHY TECHNOLOGY
  • TABLE 41 CPT CODES AND REIMBURSEMENT ANALYSIS FOR AI-BASED REMOTE PATIENT MONITORING DEVICES IN US
  • TABLE 42 AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 43 AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 44 AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 45 AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (THOUSAND UNITS)
  • TABLE 46 AI IN REMOTE PATIENT MONITORING WEARABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 47 AI IN REMOTE PATIENT MONITORING IMPLANTABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 48 AI IN REMOTE PATIENT MONITORING HANDHELD & PORTABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 49 AI IN REMOTE PATIENT MONITORING STATIONARY DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 50 AI IN REMOTE PATIENT MONITORING SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 51 AI IN REMOTE PATIENT MONITORING SERVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 52 AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 53 AI IN REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 54 AI IN REMOTE PATIENT MONITORING MARKET FOR CARDIOLOGY, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 55 AI IN REMOTE PATIENT MONITORING MARKET FOR NEUROLOGY, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 56 AI IN REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 57 AI IN REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 58 AI IN REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY DISEASES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 59 AI IN REMOTE PATIENT MONITORING MARKET FOR WELLNESS IMPROVEMENT, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 60 AI IN REMOTE PATIENT MONITORING MARKET FOR MENTAL HEALTH DISORDERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 61 AI IN REMOTE PATIENT MONITORING MARKET FOR OTHER INDICATIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 62 AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 63 AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 64 AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 65 AI IN REMOTE PATIENT MONITORING MARKET FOR HOSPITALS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 66 AI IN REMOTE PATIENT MONITORING MARKET FOR AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 67 AI IN REMOTE PATIENT MONITORING MARKET FOR LONG-TERM CARE & ASSISTED LIVING FACILITIES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 68 AI IN REMOTE PATIENT MONITORING MARKET FOR HOME HEALTHCARE FACILITIES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 69 AI IN REMOTE PATIENT MONITORING MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 70 AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 71 AI IN REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 72 AI IN REMOTE PATIENT MONITORING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 73 AI IN REMOTE PATIENT MONITORING MARKET FOR MEDTECH COMPANIES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 74 AI IN REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 75 AI IN REMOTE PATIENT MONITORING MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 76 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 77 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 78 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 79 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 80 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 81 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 82 US: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 83 US: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 84 US: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 85 US: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 86 US: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 87 CANADA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 88 CANADA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 89 CANADA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 90 CANADA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 91 CANADA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 92 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 93 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 94 EUROPE: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 95 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 96 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 97 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 98 GERMANY: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 99 GERMANY: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 100 GERMANY: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 101 GERMANY: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 102 GERMANY: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 103 UK: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 104 UK: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 105 UK: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 106 UK: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 107 UK: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 108 FRANCE: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 109 FRANCE: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 110 FRANCE: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 111 FRANCE: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 112 FRANCE: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 113 ITALY: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 114 ITALY: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 115 ITALY: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 116 ITALY: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 117 ITALY: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 118 SPAIN: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 119 SPAIN: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 120 SPAIN: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 121 SPAIN: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 122 SPAIN: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 123 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 124 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 125 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 126 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 127 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 131 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 134 CHINA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 135 CHINA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 136 CHINA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 137 CHINA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 138 CHINA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 139 JAPAN: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 140 JAPAN: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 141 JAPAN: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 142 JAPAN: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 143 JAPAN: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 144 INDIA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 145 INDIA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 146 INDIA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 147 INDIA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 148 INDIA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 149 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 150 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 151 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 152 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 153 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 154 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 155 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 156 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 157 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 158 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 159 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 160 BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 161 BRAZIL: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 162 BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 163 BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 164 BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 165 MEXICO: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 166 MEXICO: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 167 MEXICO: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 168 MEXICO: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 169 MEXICO: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 170 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 171 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 172 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 173 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 174 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 175 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 176 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 177 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 178 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 179 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 180 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 181 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 182 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 183 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 184 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 185 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 186 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
  • TABLE 187 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 188 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
  • TABLE 189 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 190 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 191 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN AI IN REMOTE PATIENT MONITORING MARKET, JANUARY 2021–JANUARY 2025
  • TABLE 192 AI IN REMOTE PATIENT MONITORING MARKET: DEGREE OF COMPETITION
  • TABLE 193 AI IN REMOTE PATIENT MONITORING MARKET: REGION FOOTPRINT
  • TABLE 194 AI IN REMOTE PATIENT MONITORING MARKET: COMPONENT FOOTPRINT
  • TABLE 195 AI IN REMOTE PATIENT MONITORING MARKET: INDICATION FOOTPRINT
  • TABLE 196 AI IN REMOTE PATIENT MONITORING MARKET: END-USER FOOTPRINT
  • TABLE 197 AI IN REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 198 AI IN REMOTE PATIENT MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 199 AI IN REMOTE PATIENT MONITORING MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 200 AI IN REMOTE PATIENT MONITORING MARKET: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 201 AI IN REMOTE PATIENT MONITORING MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025
  • TABLE 202 AI IN REMOTE PATIENT MONITORING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 203 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 204 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 205 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 206 MEDTRONIC: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 207 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 208 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 209 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 210 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 211 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 212 GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 213 GE HEALTHCARE: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 214 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 215 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 216 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025
  • TABLE 217 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 218 BOSTON SCIENTIFIC CORPORATION: EXPANSIONS, JANUARY 2021–JANUARY 2025
  • TABLE 219 BOSTON SCIENTIFIC CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 220 OMRON HEALTHCARE, INC.: COMPANY OVERVIEW
  • TABLE 221 OMRON HEALTHCARE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 222 OMRON HEALTHCARE, INC.: PRODUCT APPROVALS & ENHANCEMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 223 OMRON HEALTHCARE, INC.: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 224 RESMED, INC.: COMPANY OVERVIEW
  • TABLE 225 RESMED, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 226 RESMED, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 227 RESMED, INC.: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 228 RESMED, INC.: EXPANSIONS, JANUARY 2021–JANUARY 2025
  • TABLE 229 RESMED, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 230 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
  • TABLE 231 NIHON KOHDEN CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 232 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 233 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 234 NIHON KOHDEN CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 235 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): COMPANY OVERVIEW
  • TABLE 236 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 237 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 238 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 239 IRHYTHM INC.: COMPANY OVERVIEW
  • TABLE 240 IRHYTHM INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 241 IRHYTHM INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 242 IRHYTHM INC.: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 243 BEIJING CHOICE ELECTRONIC TECH CO., LTD.: COMPANY OVERVIEW
  • TABLE 244 BEIJING CHOICE ELECTRONIC TECH CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 245 BIOTRONIK: COMPANY OVERVIEW
  • TABLE 246 BIOTRONIK: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 247 BIOTRONIK: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 248 BIOTRONIK: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 249 ALIVECOR, INC.: COMPANY OVERVIEW
  • TABLE 250 ALIVECOR, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 251 ALIVECOR, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 252 ALIVECOR, INC.: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 253 ALIVECOR, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 254 MASIMO: COMPANY OVERVIEW
  • TABLE 255 MASIMO: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 256 MASIMO: PRODUCT APPROVALS & ENHANCEMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 257 MASIMO: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 258 DEXCOM, INC.: COMPANY OVERVIEW
  • TABLE 259 DEXCOM, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 260 DEXCOM, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 261 DEXCOM, INC.: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 262 BIOBEAT: COMPANY OVERVIEW
  • TABLE 263 BIOBEAT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 264 BIOBEAT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 265 BIOBEAT: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 266 TYTOCARE LTD.: COMPANY OVERVIEW
  • TABLE 267 TYTOCARE LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 268 TYTOCARE LTD.: PRODUCT ENHANCEMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 269 TYTOCARE LTD.: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 270 TYTOCARE LTD.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 271 ZETO INC.: COMPANY OVERVIEW
  • TABLE 272 ZETO INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 273 GLOOKO, INC.: COMPANY OVERVIEW
  • TABLE 274 GLOOKO, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 275 GLOOKO, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 276 GLOOKO, INC.: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 277 GLOOKO, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 278 WELLDOC, INC.: COMPANY OVERVIEW
  • TABLE 279 WELLDOC, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 280 WELLDOC, INC.: PRODUCT APPROVALS & ENHANCEMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 281 WELLDOC, INC.: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 282 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): COMPANY OVERVIEW
  • TABLE 283 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): PRODUCTS/SERVICES/ SOLUTIONS OFFERED
  • TABLE 284 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 285 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
  • TABLE 286 BIOINTELLISENSE, INC.: COMPANY OVERVIEW
  • TABLE 287 BLUE SPARK TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 288 ACCURKARDIA, INC.: COMPANY OVERVIEW
  • TABLE 289 AION BIOSYSTEMS, INC.: COMPANY OVERVIEW
  • TABLE 290 BROOK INC.: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 AI IN REMOTE PATIENT MONITORING MARKET SEGMENTATION & GEOGRAPHICAL SPREAD
  • FIGURE 2 AI IN REMOTE PATIENT MONITORING MARKET: YEARS CONSIDERED
  • FIGURE 3 AI IN REMOTE PATIENT MONITORING MARKET: RESEARCH DESIGN
  • FIGURE 4 AI IN REMOTE PATIENT MONITORING MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 AI IN REMOTE PATIENT MONITORING MARKET: KEY PRIMARY SOURCES
  • FIGURE 6 AI IN REMOTE PATIENT MONITORING MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 7 AI IN REMOTE PATIENT MONITORING MARKET: INSIGHTS FROM PRIMARIES
  • FIGURE 8 BREAKDOWN OF PRIMARY SOURCES: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 9 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 10 AI IN REMOTE PATIENT MONITORING MARKET: SUPPLY-SIDE MARKET ESTIMATION
  • FIGURE 11 AI IN REMOTE PATIENT MONITORING MARKET: REVENUE ESTIMATION APPROACH FOR OMRON HEALTHCARE, INC. (2023)
  • FIGURE 12 BOTTOM-UP APPROACH: END-USER SPENDING ON AI-BASED REMOTE PATIENT MONITORING SOLUTIONS
  • FIGURE 13 AI IN REMOTE PATIENT MONITORING MARKET: TOP-DOWN APPROACH
  • FIGURE 14 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2030)
  • FIGURE 15 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 16 AI IN REMOTE PATIENT MONITORING MARKET: DATA TRIANGULATION
  • FIGURE 17 AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024 VS. 2030 (USD MILLION)
  • FIGURE 18 AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024 VS. 2030 (USD MILLION)
  • FIGURE 19 AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
  • FIGURE 20 AI IN REMOTE PATIENT MONITORING MARKET: REGIONAL SNAPSHOT
  • FIGURE 21 IMPROVED MEDICAL INFRASTRUCTURE AND COST BENEFITS OF REMOTE HEALTH MONITORING TO DRIVE MARKET
  • FIGURE 22 US AND HEALTHCARE PROVIDERS TO COMMAND LARGEST NORTH AMERICAN MARKET SHARE IN 2023
  • FIGURE 23 INDIA TO REGISTER HIGHEST CAGR FROM 2024 TO 2030
  • FIGURE 24 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
  • FIGURE 25 AI IN REMOTE PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 26 US MEDIAN HEALTHCARE DATA BREACH SIZE, 2009–2024
  • FIGURE 27 AI IN REMOTE PATIENT MONITORING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • FIGURE 28 AI IN REMOTE PATIENT MONITORING MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 AI IN REMOTE PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 AVERAGE SELLING PRICE FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY TYPE (2023)
  • FIGURE 31 AI IN REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 32 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 34 PATENT PUBLICATION TRENDS IN AI IN REMOTE PATIENT MONITORING MARKET, 2015–2024
  • FIGURE 35 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS (JANUARY 2015–DECEMBER 2024)
  • FIGURE 36 TOP PATENT OWNERS/APPLICANTS IN AI IN REMOTE PATIENT MONITORING MARKET (JANUARY 2015–DECEMBER 2024)
  • FIGURE 37 AI IN REMOTE PATIENT MONITORING MARKET: FUNDING AND NUMBER OF DEALS, 2022–2024
  • FIGURE 38 US: PERCENTAGE OF NEW CANCER CASES (2024)
  • FIGURE 39 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET SNAPSHOT
  • FIGURE 40 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET SNAPSHOT
  • FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN AI IN REMOTE PATIENT MONITORING MARKET, 2019–2023 (USD MILLION)
  • FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN AI IN REMOTE PATIENT MONITORING MARKET (2023)
  • FIGURE 43 AI IN REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 44 AI IN REMOTE PATIENT MONITORING MARKET: COMPANY FOOTPRINT
  • FIGURE 45 AI IN REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 46 EV/EBITDA OF KEY VENDORS
  • FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 48 AI IN REMOTE PATIENT MONITORING MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • FIGURE 49 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 50 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 51 GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 52 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 53 OMRON HEALTHCARE, INC.: COMPANY SNAPSHOT
  • FIGURE 54 RESMED, INC.: COMPANY SNAPSHOT
  • FIGURE 55 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
  • FIGURE 56 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): COMPANY SNAPSHOT
  • FIGURE 57 IRHYTHM INC.: COMPANY SNAPSHOT
  • FIGURE 58 MASIMO: COMPANY SNAPSHOT
  • FIGURE 59 DEXCOM, INC.: COMPANY SNAPSHOT

The study involved major activities in estimating the current market size for the AI in remote patient monitoring market. Exhaustive secondary research was done to collect information on the AI in remote patient monitoring industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the AI in remote patient monitoring market.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of AI in remote patient monitoring market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global AI in remote patient monitoring market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews

Breakdown of Primary Participants

AI in Remote Patient Monitoring (RPM) Market

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2: Tiers of companies are defined on the basis of their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the AI in remote patient monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.

The research methodology used to estimate the market size includes the following:

AI in Remote Patient Monitoring (RPM) Market

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the AI in remote patient monitoring market.

Market Definition

The AI in Remote Patient Monitoring (RPM) refers to the integration of artificial intelligence (AI) technologies into AI in remote patient monitoring systems to enhance the collection, analysis, and interpretation of patient health data. This combination allows for more proactive, personalized, and efficient healthcare delivery outside of traditional clinical settings.

Stakeholders

  • RPM Equipment and devices Manufacturers
  • Suppliers and Distributors of RPM Equipment
  • RPM software provider
  • Healthcare IT Service Providers
  • Healthcare Insurance Companies/Payers
  • Healthcare Institutions/Providers (Hospitals, Clinics, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
  • Venture Capitalists
  • Government Bodies/Regulatory Bodies
  • Corporate Entities
  • Accountable Care Organizations
  • RPM Resource Centers
  • Research and Consulting Firms
  • Medical Research Institutes
  • Clinical Departments

Report Objectives

  • To define, describe, and forecast the global AI in remote patient monitoring market based on component, indication, end user, and region.
  • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
  • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall AI in remote patient monitoring market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To strategically analyze the market structure profile of the key players of the AI in remote patient monitoring market and comprehensively analyze their core competencies.
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • To track and analyze competitive developments such as product launches and enhancements and investments, partnerships, collaborations, acquisitions, expansions, funding, grant, agreements, sales contracts, product testing, FDA approval, product approval, and alliances in the AI in remote patient monitoring market during the forecast period.

Previous Versions of this Report

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in AI in Remote Patient Monitoring (RPM) Market

DMCA.com Protection Status